Liesbeth Van Wesenbeeck

2.5k citations

38 papers · 1.7k indexed · h-index 21

Virology top 5%
- HIV Research and Treatment 7
Orthopedics and Sports Medicine top 5%
Oncology top 5%
- Bone health and treatments 16
Molecular Biology top 10%
- Bone Metabolism and Diseases 12
- Biochemical and Molecular Research 4
- Wnt/β-catenin signaling in development and cancer 4
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 8
Epidemiology
- Influenza Virus Research Studies 6
- Respiratory viral infections research 6

Co-authors: Wim Van Hul Wendy Balemans Erna Cleiren Matthew L. Warman Jens Bollerslev Jeppe Gram Lieven Stuyver Domenico Scopelliti
Cited by: Virology Orthopedics and Sports Medicine Oncology
Partner nations: Belgium United States United Kingdom

In The Last Decade

Liesbeth Van Wesenbeeck

37 papers receiving 1.7k citations

Peers

Countries citing papers authored by Liesbeth Van Wesenbeeck

Since Specialization

Citations

This map shows the geographic impact of Liesbeth Van Wesenbeeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liesbeth Van Wesenbeeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liesbeth Van Wesenbeeck more than expected).

Fields of papers citing papers by Liesbeth Van Wesenbeeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liesbeth Van Wesenbeeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liesbeth Van Wesenbeeck. The network helps show where Liesbeth Van Wesenbeeck may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Liesbeth Van Wesenbeeck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liesbeth Van Wesenbeeck Line = papers co-authored together Liesbeth Van Wesenbeeck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab Kim Thys,Matthew J. Loza,L A Lynn,Katleen Callewaert,Lisa Varma,Marjolein Crabbe,Liesbeth Van Wesenbeeck,Erika Van Landuyt,Sandra De Meyer,Jeroen Aerssens,Inge Verbrugge	2024	0
2	The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19 Robert Gottlieb,Meredith E. Clement,Paul Cook,Audra Deveikis,Kap Sum Foong,Philip A. Robinson,Jihad Slim,Cedric W. Spak,Annemie Buelens,Katleen Callewaert,Sandra De Meyer,Wai Ling Mo,Inge Verbrugge,Liesbeth Van Wesenbeeck,Yanli Zhuang,Jason W. Chien,Magda Opsomer,Erika Van Landuyt	2024	2
3	Evolution of inflammation and immunity in a dengue virus 1 human infection model Adam T. Waickman,Joseph Q. Lu,Hengsheng Fang,Mitchell J. Waldran,Chad Gebo,Jeffrey R. Currier,Lisa A. Ware,Liesbeth Van Wesenbeeck,Nathalie Verpoorten,Oliver Lenz,Lotke Tambuyzer,Guillermo Herrera‐Taracena,Marnix Van Loock,Timothy P. Endy,Stephen J. Thomas	2022	23
4	Sampling and detection of airborne influenza virus towards point-of-care applications Laila Ladhani,Gaspard Pardon,Hanne Meeuws,Liesbeth Van Wesenbeeck,Kristiane Schmidt,Lieven Stuyver,Wouter van der Wijngaart	2017	40
5	Sampling variability between two mid-turbinate swabs of the same patient has implications for influenza viral load monitoring Liesbeth Van Wesenbeeck,Hanne Meeuws,David D’Haese,Gabriela Ispas,Lieselot Houspie,Marc Van Ranst,Lieven Stuyver	2014	18
6	Evaluation of a proximity extension assay for the detection of H1 2009 pandemic influenza viruses Liesbeth Van Wesenbeeck,Hanne Meeuws,Hans Wolf,Lieven Stuyver	2013	3
7	Quantitative prediction of integrase inhibitor resistance from genotype through consensus linear regression modeling Koen Van der Borght,Ann Verheyen,Maxim Feyaerts,Liesbeth Van Wesenbeeck,Yvan Verlinden,Elke Van Craenenbroeck,Herman van Vlijmen	2013	9
8	Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing Daniele Armenia,Ina Vandenbroucke,Lavinia Fabeni,Herwig Van Marck,Valeria Cento,Roberta D’Arrigo,Liesbeth Van Wesenbeeck,Fernanda Scopelliti,Valeria Micheli,Bianca Bruzzone,Sergio Lo Caputo,Jeroen Aerssens,Giuliano Rizzardini,Valerio Tozzi,Pasquale Narciso,Andrea Antinori,Lieven Stuyver,Carlo Federico Perno,Francesca Ceccherini‐Silberstein	2012	46
9	Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor Olivia Goethals,Marcia Van Ginderen,Ann Vos,Maxwell D. Cummings,Koen Van der Borght,Liesbeth Van Wesenbeeck,Maxim Feyaerts,Ann Verheyen,Veerle Smits,Marnix Van Loock,Kurt Hertogs,Dominique Schols,R. Clayton	2011	26
10	The neurology of carbonic anhydrase type II deficiency syndrome Thomas M. Bosley,Mustafa A. Salih,Ibrahim A. Alorainy,Mohammad Zahirul Islam,Darren T. Oystreck,Omer S M Suliman,Salem Al Malki,A. H. Suhaibani,H. Khiari,Sigri Beckers,Liesbeth Van Wesenbeeck,Bram Perdu,Abdulmajeed AlDrees,Salah A. Elmalik,Wim Van Hul,Khaled K. Abu‐Amero	2011	27
11	HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens D. da Silva,Liesbeth Van Wesenbeeck,Dominique Breilh,S. Reigadas,Guerric Anies,Karen Van Baelen,Philippe Morlat,D. Neau,M. Dupon,Linda Wittkop,Heloísa Junqueira Fleury,Bernard Masquelier	2010	54
12	Refined Genomic Localization of the Genetic Lesion in the Osteopetrosis (op) Rat and Exclusion of Three Positional and Functional Candidate Genes, Clcn7, Atp6v0c, and Slc9a3r2 Bram Perdu,Paul R. Odgren,Liesbeth Van Wesenbeeck,Karen Jennes,Carol MaCkay,Wim Van Hul	2009	5
13	Founder Effect in Different European Countries for the Recurrent P392L SQSTM1 Mutation in Paget’s Disease of Bone Pui Yan Jenny Chung,Greet Beyens,Núria Guañabens,Steven Boonen,Socrates E. Papapoulos,Marcel Karperien,Elisabeth M. W. Eekhoff,Liesbeth Van Wesenbeeck,Karen Jennes,Piet Geusens,Erwin Offeciers,Jan Van Offel,René Westhovens,Hans Zmierczak,Jean‐Pierre Devogelaer,Wim Van Hul	2008	29
14	The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations Wendy Balemans,Elke Piters,Erna Cleiren,Minrong Ai,Liesbeth Van Wesenbeeck,Matthew L. Warman,Wim Van Hul	2008	113
15	Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans Liesbeth Van Wesenbeeck,Paul R. Odgren,Fraser P. Coxon,Annalisa Frattini,Pierre Moens,Bram Perdu,Carole A. MacKay,Els Van Hul,Jean‐Pierre Timmermans,Filip Vanhoenacker,Reinhilde Jacobs,Barbara Peruzzi,Anna Teti,Miep Helfrich,Michael J. Rogers,Anna Villa,Wim Van Hul	2007	163
16	A Clinical and Molecular Overview of the Human Osteopetroses Wendy Balemans,Liesbeth Van Wesenbeeck,Wim Van Hul	2005	100
17	Lessons from Osteopetrotic Mutations in Animals: Impact on Our Current Understanding of Osteoclast Biology Liesbeth Van Wesenbeeck,Wim Van Hul	2005	23
18	Six Novel Missense Mutations in the LDL Receptor-Related Protein 5 (LRP5) Gene in Different Conditions with an Increased Bone Density Liesbeth Van Wesenbeeck,Erna Cleiren,Jeppe Gram,Rodney K. Beals,Olivier Bénichou,Domenico Scopelliti,Lyndon Key,Tara Renton,Cindy Aguilar Bartels,Yaoqin Gong,Matthew L. Warman,Marie‐Christine de Vernejoul,Jens Bollerslev,Wim Van Hul	2003	426
19	Evidence that the rat osteopetrotic mutation toothless (tl) is not in the TNFSF11 (TRANCE, RANKL, ODF, OPGL) gene Paul R. Odgren,Nayoung Kim,Liesbeth Van Wesenbeeck,Charles R. Mackay,April Mason‐Savas,Fayez Safadi,Steven N. Popoff,Christopher J. Lengner,Wim Van Hul,Yongwon Choi,Sandy C. Marks	2001	9
20	Evaluation of the role of RANK and OPG genes in Paget’s disease of bone Wim Wuyts,Liesbeth Van Wesenbeeck,Antonio Morales‐Piga,Stuart H. Ralston,Lynne J. Hocking,Filip Vanhoenacker,René Westhovens,Leon Verbruggen,Dirk Anderson,A Hughes,Wim Van Hul	2001	89

About Liesbeth Van Wesenbeeck

Liesbeth Van Wesenbeeck is a scholar working on Virology, Infectious Diseases and Oncology, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bone health and treatments (16 papers), Bone Metabolism and Diseases (12 papers), HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (7 papers), Influenza Virus Research Studies (6 papers), Respiratory viral infections research (6 papers), Biochemical and Molecular Research (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). The work is most often cited by research in Virology (201 citations), Orthopedics and Sports Medicine (230 citations) and Oncology (535 citations). Liesbeth Van Wesenbeeck has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Wim Van Hul, Wendy Balemans, Erna Cleiren, Matthew L. Warman, Jens Bollerslev, Jeppe Gram, Lieven Stuyver, Domenico Scopelliti, Marie‐Christine de Vernejoul and Yaoqin Gong.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact